Even in tumors with elevated expressions of the HH target genes GLI1 and PTCH1, the expression of SHH, as a canonical driver of the HH pathway, is not necessarily high, suggesting other mechanisms of HH signaling activation in cancer [38]. This evidence concerns the gene PTCH1 and cancer.